Navigation Links
TorreyPines Therapeutics Reports Third Quarter 2007 Results
Date:11/14/2007

ely to change and speak only as of the date hereof.

(Tables Follow)

TorreyPines Therapeutics, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

September 30, December 31,

2007 2006

(Unaudited)

Assets

Current assets

Cash and cash equivalents $39,723 $55,383

Prepaid expenses and other current assets 289 581

Total current assets 40,012 55,964

Long-term assets 7,025 7,471

Total assets $47,037 $63,435

Liabilities and stockholders' equity

Current liabilities $8,745 $12,270

Debt and other long-term liabilities 1,871 4,413

Deferred revenue 2,083 2,183

Total liabilities 12,699 18,866

Total stockholders' equity 34,338 44,569

Total liabilities and stockholders' equity $47,037 $63,435

TorreyPines Therapeutics, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(Unaudited)

Three months ended Nine months ended

September 30, September 30,

2007 2006 2007 2006

Revenue $2,463 $2,463 $7,388 $7,388

Operating expenses:

Resea
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014 Pfanstiehl ... Mannose (USP/NF, EP), manufactured in the ... "Mannose has long been recognized for playing a ... a growing body of evidence that media supplementation ... consistency of protein glycosylation," according to Dr. ...
(Date:10/1/2014)... (PRWEB) September 30, 2014 Today ... initial round of grants for the Brain Research ... that aims to develop and revolutionize new methods ... of the human brain. This first round of ... year 2014 was allocated to more than 100 ...
(Date:10/1/2014)... September 30, 2014 Award winning ... announces four new-hosted collaboration bundles that combine ... high quality conferencing experiences for low, flat rate ... choose from, businesses have optimized solutions to meet ... include audio only minutes (1K, 5K, 10K ...
(Date:10/1/2014)... October 01, 2014 The U.S. Department ... Southern Illinois University Edwardsville as part of the Trade ... The funding is co-administered by the Department of Labor ... Secretary of Labor Thomas E. Perez and Secretary of ... in job-driven training grants to nearly 270 colleges across ...
Breaking Biology Technology:Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization & Glycoprotein Biosynthesis 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3SoundConnect Launches New Audio, Web and Video Bundles 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4
... Clinical Study Demonstrates Breakthrough Dose-Sparing Formulation,That Increases Stockpile ... Doses in a Pandemic Situation Sanofi pasteur, ... showing that its new investigational H5N1 pandemic influenza,vaccine ... response,at the lowest dose of H5N1 antigen reported ...
... often deal with the same problems, but they use ... can be difficult, if not impossible., A new $2.9 ... the National Science Foundation (NSF), will help bridge this ... solve common problems a range of scientists face., The ...
... 17 DaVita Inc.,(NYSE: DVA ) today announced ... Conference in London on Thursday, September 20, 2007 at ... access the live webcast, go to http://www.ibb.ubs.com, ... page, followed by the webcast link,listed next to the ...
Cached Biology Technology:Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5CCMR gets $2.9M for training grad students in nanoscale science 2
(Date:10/2/2014)... SHELTON, Conn. , Oct. 2, 2014 NXT-ID, ... focused on the growing mobile commerce market, announces the airings ... Money and Mad Money. The national ads resumed ... will air October 2 nd and October 3 rd ... The continuing ads that began airing on CNBC ...
(Date:10/1/2014)... take a healthy salad up a level by growing ... in leafy greens. , "In the long run, one ... the salad or making a pill from the plant ... at Case Western Reserve School of Medicine and leader ... cancer organization is funding the research with a three-year, ...
(Date:9/30/2014)... tourists visit the Mediterranean each year, but its ... on Earth. Almost 1,000 alien species, including fish, ... seas through human activities. In the open-access journal ... team of researchers analyzed data from a new ... show how the introduction of alien species has ...
Breaking Biology News(10 mins):CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 2CNBC Commercial Airings for Wocket Smart Wallet October 2nd and 3rd 3Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Biodiversity in the Mediterranean is threatened by alien species 2
... forms from solution is a problem that has occupied ... (TU/e), together with researchers from Germany and the USA, ... of crystal formation, which occurs widely in nature and ... years, but is saved now. The team made this ...
... known that horses show symptoms of stress when ridden but ... their riders. This is surprising, as equestrian sports rely ... How does the horse-rider team cope with the stress ... has now been studied by Mareike von Lewinski in the ...
... 2013 Raman spectroscopy has enabled incredible advances ... tool for tissue classification and disease recognition, although ... method in a clinical setting. Scientists have now ... the door to wider biomedical and clinical applications ...
Cached Biology News:Theory of crystal formation complete again 2Theory of crystal formation complete again 3Horses don't have stage fright -- but their riders do 2Breakthrough study opens door to broader biomedical applications for Raman spectroscopy 2
Profilin-1/2 (FL-140)...
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Biology Products: